An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
Clinical trial NCT05835310 · RECRUITING
Trial details
- NCT number
- NCT05835310
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-14
- Primary completion
- 2028-10-05
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.